欢迎来到《四川大学学报(医学版)》

后巩膜加固术与巩膜胶原交联术在高度近视治疗中的研究进展

Advances in Posterior Scleral Reinforcement and Scleral Collagen Cross-Linking for the Treatment of High Myopia

  • 摘要: 近视,尤其是高度近视,已成为全球范围内重要的公共卫生问题。在近视进展过程中,巩膜重塑被认为是眼轴延长的核心机制,具体表现为巩膜组织结构、细胞外基质代谢及生物力学特性的持续性改变。目前,以巩膜为靶点控制高度近视进展的手术主要分为两类:一是利用生物材料或人工合成材料加固眼球后极部的后巩膜加固术(posterior scleral reinforcement, PSR);二是通过提高巩膜胶原纤维稳定性的巩膜胶原交联术(scleral collagen cross-linking, SXL)。本文围绕PSR及SXL的作用机制、材料与术式、疗效及安全性等方面进行系统综述,旨在探讨以巩膜为靶点治疗高度近视手术的临床应用前景,为临床近视防控提供参考。

     

    Abstract: Myopia, particularly high myopia, has become a major global public health concern. During myopia progression, scleral remodeling is considered a key mechanism underlying axial elongation and is characterized by continuous alterations in scleral tissue structure, extracellular matrix metabolism, and biomechanical properties. Currently, surgical approaches targeting the sclera to control the progression of high myopia can be broadly classified into 2 categories. The first one is posterior scleral reinforcement (PSR), which reinforces the posterior pole of the globe using biological or synthetic materials. The second one is scleral collagen cross-linking (SXL), which enhances the stability of scleral collagen fibers. This review systematically summarizes the mechanisms, materials and surgical approaches, efficacy, and safety of PSR and SXL, with the aim of evaluating the clinical application prospects of sclera-targeted surgical interventions for the treatment of high myopia and informing clinical myopia management.

     

/

返回文章
返回